LSIPR, Gowling WLG team up for biologics survey
22-06-2021
LSIPR webinar: HGF delves into personalised healthcare patents
13-09-2018
LSIPR Webinar: Greater scrutiny for late-filed EPO documents, says HGF
22-03-2018
Dmitrii_Guzhanin / iStockphoto.com
The case of Actavis v Eli Lilly introduced “a real change in the law” and the way in which it addresses the doctrine of equivalence, according to Douglas Drysdale, partner at HGF in Glasgow, UK.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Webinar, Douglas Drysdale, HGF, Actavis v Lilly, Improver, patent infringement test, patent claim scope, invention, doctrine of equivalence, Lord Neuberger
